Brokers rate these 2 top ASX shares as buys in May 2022

Elmo and Capitol Health are two ASX shares brokers are liking.

| More on:
A woman sits at her computer with hand to mouth and a contemplative smile on her face although she is considering or thinking about information she is seeing on the screen.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Brokers rate both of these ASX shares as a buy in May 2022
  • Elmo Software is an HR software business
  • Capital Health is a diagnostic imaging company

Can you believe May 2022 is here already? There are a number of ASX shares brokers rate as buys this month.

This article is about two smaller businesses that could be opportunities for investors to consider.

Here are two buy-rated stocks:

Elmo Software Ltd (ASX: ELO)

Elmo Software is an ASX tech share that provides HR and payroll software to small and medium businesses in Australia and the UK.

The Elmo Software share price has fallen 32% since the start of the 2022 calendar year.

Broker Morgan Stanley currently rates the ASX share as a buy with a price target of $7.80. That implies a possible rise of around 150% over the next year.

The company’s FY22 first half result included growth in a number of areas for the business. Annualised recurring revenue (ARR) rose by 35% to $98.3 million, while reported revenue rose 41% to $43.1 million.

In that result, Elmo was able to report a positive earnings before interest, tax, depreciation and amortisation (EBITDA) after it rose by $0.9 million to $0.3 million.

Due to “strong trading conditions” and increased adoption of cloud-software solutions by businesses to manage remote and hybrid workforces, Elmo upgraded its FY22 ARR guidance to $107 million to $113 million.

Elmo said that “operating leverage continues to improve with a reduction in key spend ratios across the business”.

Capitol Health Ltd (ASX: CAJ)

Capitol Health describes itself as a leading provider of diagnostic imaging and related services to the Australian healthcare market. It has clinics across Victoria, Tasmania, South Australia, and Western Australia.

The Capitol Health share price has fallen by 17% since the start of 2022.

The ASX share is currently rated as a buy by Ord Minnett with a price target of $0.44. That implies a possible upside of more than 30%.

Ord Minnett thinks the business has demonstrated the defensive nature of its earnings and that the end of COVID-19 will help the business.

In the first six months of FY22, Capitol Health announced that revenue rose by 11.2% to $94.9 million. Operating EBITDA grew by 6.9% to $22.2 million. Statutory net profit after tax (NPAT) jumped 30.2% to $8.1 million.

The company is looking to expand its network through both bolt-on acquisitions and the opening of greenfield/brownfield locations. It’s also developing various synergies from the acquisition and opening of clinics. The ASX share is working on becoming more efficient by standardising its processes across its clinics.

According to Ord Minnett’s projections, the Capitol Health share price is valued at 24 times FY22’s estimated earnings with a grossed-up dividend yield of 4.3%.

JPMorgan Chase is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Elmo Software. The Motley Fool Australia has positions in and has recommended Elmo Software. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate
Broker Notes

Why analysts say investors should buy these top ASX shares

Analysts are saying that these shares are in the buy zone…

Read more »

best asx shares represented by best in show ribbon
Broker Notes

3 more of Morgans’ best ASX share ideas for July

These three ASX shares are highly rated...

Read more »

ASX shares Business man marking buy on board and underlining it
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers rate these ASX shares as buys...

Read more »

A female construction project manager in a hi vis vest and hard hat considers progress on a chart on the wall.
Broker Notes

Down 10% in a month, could Boral shares be a buy?

Some are still constructive on the construction player's shares.

Read more »

A man sits at a desk holding a small replica house in his hand, upset at the sale of his property.
Broker Notes

Why did the Goodman share price suffer a sell-off in June?

June was a difficult month for many ASX shares, including Goodman.

Read more »

A little boy surrounded by green grass and trees looks up at the sky, waiting for rain or sunshine.
Bank Shares

Could the CBA share price turn over a new leaf in July?

Here's what brokers are thinking about the big four ASX bank.

Read more »

Happy woman looking through two doughnuts like binoculars
Technology Shares

Should investors zero in on the Xero share price in July?

Is this ASX tech share now too cheap to ignore?

Read more »

Red buy button on an apple keyboard with a finger on it representing asx tech shares to buy today
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers are feeling positive about these ASX shares...

Read more »